Bank of America Securities Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)
In a report released yesterday, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report), with a price target of $80.00. The company's shares closed yesterday at $34.72.
Confident Investing Starts Here:
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Ahmad is an analyst with an average return of -5.3% and a 43.00% success rate. Ahmad covers the Healthcare sector, focusing on stocks such as Sarepta Therapeutics, PTC Therapeutics, and Alnylam Pharma.
In addition to Bank of America Securities, Ultragenyx Pharmaceutical also received a Buy from Morgan Stanley's Maxwell Skor in a report issued on May 8. However, on May 7, Wedbush maintained a Hold rating on Ultragenyx Pharmaceutical (NASDAQ: RARE).
RARE market cap is currently $3.41B and has a P/E ratio of -6.02.
Based on the recent corporate insider activity of 47 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of RARE in relation to earlier this year. Earlier this month, Eric Crombez, the EVP and Chief Medical Officer of RARE sold 242.00 shares for a total of $8,496.62.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
37 minutes ago
- Business Insider
Stifel Nicolaus Sticks to Their Hold Rating for Boyd Gaming (BYD)
In a report released yesterday, Steven Wieczynski from Stifel Nicolaus maintained a Hold rating on Boyd Gaming (BYD – Research Report), with a price target of $76.00. The company's shares closed yesterday at $73.93. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Wieczynski is a 5-star analyst with an average return of 10.2% and a 48.35% success rate. Wieczynski covers the Consumer Cyclical sector, focusing on stocks such as Royal Caribbean, Boyd Gaming, and Las Vegas Sands. Currently, the analyst consensus on Boyd Gaming is a Moderate Buy with an average price target of $79.71, a 7.82% upside from current levels. In a report released on May 30, Morgan Stanley also maintained a Hold rating on the stock with a $76.00 price target. Based on Boyd Gaming's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $991.57 million and a net profit of $110.35 million. In comparison, last year the company earned a revenue of $960.52 million and had a net profit of $136.47 million
Business Insider
37 minutes ago
- Business Insider
RBC Capital Sticks to Its Hold Rating for CME Group (CME)
RBC Capital analyst Ashish Sabadra maintained a Hold rating on CME Group (CME – Research Report) on June 8 and set a price target of $269.00. The company's shares closed yesterday at $268.35. Confident Investing Starts Here: Sabadra covers the Industrials sector, focusing on stocks such as APi Group, Cintas, and Equifax. According to TipRanks, Sabadra has an average return of 6.1% and a 62.50% success rate on recommended stocks. In addition to RBC Capital, CME Group also received a Hold from KBW's Kyle Voigt in a report issued on June 4. However, on the same day, Oppenheimer reiterated a Buy rating on CME Group (NASDAQ: CME). CME market cap is currently $98.82B and has a P/E ratio of 27.57. Based on the recent corporate insider activity of 99 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CME in relation to earlier this year. Last month, Daniel Kaye, a Director at CME sold 500.00 shares for a total of $141,205.00.
Business Insider
37 minutes ago
- Business Insider
Vail Resorts (MTN) Receives a Buy from Stifel Nicolaus
analyst Jeffrey Stantial maintained a Buy rating on Vail Resorts (MTN – Research Report) yesterday and set a price target of $180.00. The company's shares closed yesterday at $155.68. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Stantial covers the Consumer Cyclical sector, focusing on stocks such as Vail Resorts, International Game Technology, and Light & Wonder. According to TipRanks, Stantial has an average return of -1.7% and a 37.80% success rate on recommended stocks. In addition to Stifel Nicolaus, Vail Resorts also received a Buy from Mizuho Securities's Benjamin Chaiken in a report issued on June 6. However, yesterday, Barclays maintained a Sell rating on Vail Resorts (NYSE: MTN). The company has a one-year high of $199.45 and a one-year low of $129.85. Currently, Vail Resorts has an average volume of 729.5K. Based on the recent corporate insider activity of 34 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of MTN in relation to earlier this year. Most recently, in March 2025, Korch Angela A, the EVP & CFO of MTN bought 185.00 shares for a total of $29,600.00.
